Press Releases DiaSorin S.p.A.

Equities

DIA

IT0003492391

Market Closed - Borsa Italiana Other stock markets 09:14:59 29/04/2024 pm IST			5-day change	1st Jan Change
96.24 ^EUR	+1.41%		+5.55%	+3.22%

24/04	Citadel Advisors initiates short on STMicroelectronics.	AN
23/04	Reduced a short on DiaSorin, increased on STM.	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DiaSorin S p A : submits LIAISON PLEX® Yeast Blood Culture Assay for the LIAISON PLEX® system to the U.S. FDA	13/03	PU
Diasorin unveils its new Corporate identity and launches the new Group website: www.diasorin.com	24/23/24	PU
DiaSorin S p A : Half-Year Financial Report at June 30, 2023	03/23/03	PU
DiaSorin S p A : Presentazione Risultati H1 2023	27/23/27	PU
DiaSorin S p A : launches the LIAISON® Legionella Urinary Ag assay in all countries accepting the CE Mark to improve diagnosis of legionnaires’ disease	17/23/17	PU
DiaSorin S p A : launches the LIAISON® B·R·A·H·M·S MR-proADM™ assay in all countries accepting the CE Mark	13/23/13	PU
DiaSorin S p A : CONSOLIDATES STRATEGIC PARTNERSHIP WITH MEMED BY SIGNING AN AGREEMENT TO DISTRIBUTE MEMED BV® TEST FOR THE ITALIAN MARKET ON THE MEMED KEY® POINT-OF-NEED PLATFORM	26/23/26	PU
DiaSorin S p A : Presentazione Risultati Q1 2023	09/23/09	PU
DiaSorin S p A : Annual Financial Report at December 31, 2022	28/23/28	PU
DiaSorin S p A : Presentazione Risultati FY 2022	27/23/27	PU
DiaSorin S p A : Simplexa® cCMV Direct assay received U.S. FDA 510(K) clearance	09/22/09	PU
DiaSorin S p A : - 9M 2022 results presentation	27/22/27	PU
DiaSorin S p A : - Presentazione risultati primi 9 mesi 2022	27/22/27	PU
DiaSorin S p A : furthers its collaboration with BARDA for the LIAISON NES	05/22/05	PU
DiaSorin S p A : Roadshows Presentation -Settembre 2022	13/22/13	PU
DiaSorin S p A : Half-Year Financial Report at June 30, 2022	09/22/09	PU
DiaSorin S p A : Strong revenues growth in the First Half of 2022 - Full Year 2022 Guidance on both Revenues and Profitability revised upwards	03/22/03	PU
DiaSorin S p A : risultati H1 2022	03/22/03	PU
DiaSorin S p A : receives FDA 510(k) clearance for its LIAISON® MeMed BV® test	14/22/14	PU
DiaSorin S p A : Execution of the project for the redefinition of the corporate structure of DiaSorin	07/22/07	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DIASORIN : Profitability guidance miss; dreams inching towards reality

March 18, 2024 at 02:54 pm IST